These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31259853)

  • 1. Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis.
    Chambers LC; Jensen JS; Morgan JL; Lowens MS; Romano SS; Totten PA; Soge OO; Hughes JP; Golden MR; Manhart LE
    Sex Transm Dis; 2019 Dec; 46(12):805-809. PubMed ID: 31259853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.
    Murray GL; Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Fairley CK; Jensen JS; Williamson DA; Tan LY; Mokany E; Durukan D; Bradshaw CS
    J Infect Dis; 2020 Mar; 221(6):1017-1024. PubMed ID: 32031634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of
    Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34590993
    [No Abstract]   [Full Text] [Related]  

  • 4. Men Who Have Sex With Men With Mycoplasma genitalium-Positive Nongonococcal Urethritis Are More Likely to Have Macrolide-Resistant Strains Than Men With Only Female Partners: A Prospective Study.
    McIver R; Jalocon D; McNulty A; Jeoffreys NJ; Chen SC; Power M; Couldwell DL
    Sex Transm Dis; 2019 Aug; 46(8):513-517. PubMed ID: 31295218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.
    Vodstrcil LA; Plummer EL; Doyle M; Murray GL; Bodiyabadu K; Jensen JS; Whiley D; Sweeney E; Williamson DA; Chow EPF; Fairley CK; Bradshaw CS
    Clin Infect Dis; 2022 Sep; 75(5):813-823. PubMed ID: 34984438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Read TR; Fairley CK; Tabrizi SN; Bissessor M; Vodstrcil L; Chow EP; Grant M; Danielewski J; Garland SM; Hocking JS; Chen MY; Bradshaw CS
    Clin Infect Dis; 2017 Feb; 64(3):250-256. PubMed ID: 28011607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.
    Jensen JS; Bradshaw CS; Tabrizi SN; Fairley CK; Hamasuna R
    Clin Infect Dis; 2008 Dec; 47(12):1546-53. PubMed ID: 18990060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
    Pond MJ; Nori AV; Witney AA; Lopeman RC; Butcher PD; Sadiq ST
    Clin Infect Dis; 2014 Mar; 58(5):631-7. PubMed ID: 24280088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan.
    Deguchi T; Ito S; Yasuda M; Kondo H; Yamada Y; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M
    J Infect Chemother; 2017 Sep; 23(9):648-650. PubMed ID: 28462860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
    Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M
    BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain.
    Barberá MJ; Fernández-Huerta M; Jensen JS; Caballero E; Andreu A
    Sex Transm Dis; 2017 Aug; 44(8):457-462. PubMed ID: 28703723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin, minocycline, moxifloxacin and spectinomycin failure in a case with persistent
    Yang L; Ke W
    Int J STD AIDS; 2020 Oct; 31(11):1106-1109. PubMed ID: 32842908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of antibiotic-resistant Mycoplasma genitalium as the cause of non-gonococcal urethritis in male patients at a sexually transmitted infection clinic.
    Lee SS; Cheng KF; Wong NS; Kwan CK; Lau OC; Cheng HF; Ngan W; Ma SP; Kam KM; Ho KM; Chung PH; Chan DPC
    Int J Antimicrob Agents; 2022 Feb; 59(2):106510. PubMed ID: 34971729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
    Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
    J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report.
    Falk L; Jensen JS
    J Antimicrob Chemother; 2017 Feb; 72(2):624-625. PubMed ID: 27707988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.